Medicin mod hjertekar- og nyresygdom

from Diabetesforskerne · host Steno Diabetes Center

Sotagliflozin er medicin til personer med type 2-diabetes, som forbedrer blodsukker og blodtryk.Medicinen nedsætter også risikoen for forværringen af hjertekar- og nyresygdomme.Nyt studie tyder på, det kan have samme gavnlige effekter på hjerte og nyrer for personer med type 1-diabetes.ForskerElisabeth Stougaard, læge og ph.d. på Steno Diabetes Center Copenhagen VærtSimon BrixDiabetesforskerne er udgivet af de 7 Steno Diabetes Centre og produceret af Kontekst & Lyd

Episode metadata supplied by the publisher feed · Published Mar 1, 2023

Embed this episode

Attribution link and audio player

Ready to play

Medicin mod hjertekar- og nyresygdom

0:00 16:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Diabetesforskerne?

This episode is 16 minutes long.

When was this Diabetesforskerne episode published?

This episode was published on March 1, 2023.

Can I download this Diabetesforskerne episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!